Screening Mammography for Women 40 to 49 Years of Age: A Clinical Practice Guideline from the American College of Physicians

  1. Amir Qaseem, MD, PhD, MHA;
  2. Vincenza Snow, MD;
  3. Katherine Sherif, MD;
  4. Mark Aronson, MD;
  5. Kevin B. Weiss, MD, MPH;
  6. Douglas K. Owens, MD, MS; and
  7. for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians*
  1. From the American College of Physicians and Drexel University College of Medicine, Philadelphia, Pennsylvania; Beth Israel Deaconess Medical Center, Boston, Massachusetts; Hines Veterans Affairs Hospital and Northwestern University, Chicago, Illinois; and Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, California.

    Abstract

    Breast cancer is one of the most common causes of death for women in their 40s in the United States. Individualized risk assessment plays an important role when making decisions about screening mammography, especially for women 49 years of age or younger. The purpose of this guideline is to present the available evidence for screening mammography in women 40 to 49 years of age and to increase clinicians' understanding of the benefits and risks of screening mammography.

    *This paper, written by Amir Qaseem, MD, PhD, MHA; Vincenza Snow, MD; Katherine Sherif, MD; Mark Aronson, MD; Kevin B. Weiss, MD, MPH; and Douglas K. Owens, MD, MS, was developed for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians (ACP): Douglas K. Owens, MD, MS (Chair); Mark Aronson, MD; Patricia Barry, MD, MPH; Donald E. Casey Jr., MD, MPH, MBA; J. Thomas Cross Jr., MD, MPH; Nick Fitterman, MD; E. Rodney Hornbake, MD; Katherine D. Sherif, MD; and Kevin B. Weiss, MD, MPH (Immediate Past Chair). Approved by the ACP Board of Regents on 15 July 2006.

    Article and Author Information

    • Note: Clinical practice guidelines are guides only and may not apply to all patients and all clinical situations. Thus, they are not intended to override clinicians' judgment. All ACP clinical practice guidelines are considered automatically withdrawn or invalid 5 years after publication or once an update has been issued.

    • Annals of Internal Medicine encourages readers to copy and distribute this paper, provided that such distribution is not for profit. Commercial distribution is not permitted without the express permission of the publisher.

    • Grant Support: Financial support for the development of this guideline comes exclusively from the ACP operating budget.

    • Potential Financial Conflicts of Interest:Grants received: V. Snow (Agency for Healthcare Research and Quality, Centers for Disease Control and Prevention, Atlantic Philanthropies).

    • Requests for Single Reprints: Amir Qaseem, MD, PhD, MHA, American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA 19106; e-mail, aqaseem{at}acponline.org.

    • Current Author Addresses: Drs. Qaseem and Snow: American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA 19106.

    • Dr. Sherif: 219 North Broad Street, 6th Floor, Philadelphia, PA 19107.

    • Dr. Aronson: 330 Brookline Avenue, Boston, MA 02215.

    • Dr. Weiss: PO Box 5000, Hines, IL 60141.

    • Dr. Owens: 117 Encina Commons, Stanford, CA 94305.

    Responses to this article

    Related Article

    Summaries for Patients

    « Previous | Next Article »Table of Contents